Pharma Reviews: Pain for big Indian pharma companies continue warns CRISIL, as FDA woes remains unresolved

MUMBAI: Rating agency CRISIL has warned that woes of Indian generic companies will continue as the regulatory action by the US Food and Drug ...
Read more: Pain for big Indian pharma companies continue warns CRISIL, as FDA woes remains unresolved